OptiNose OPTN 深 滬
等待開盤 07-25 09:30:00 美东时间
9.60
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 9.60
- 總市值 9722.30万
- 52周最高 20.025
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.815
- 委 比 0.00%
- 總股本 1012.74万
- 歷史最高 450.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 4.815
- 每 手 1
- 風險率 3.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多'HHS Finds Systemic Disregard for Sanctity of Life in Organ Transplant System; To Begin Reforming Organ Transplant System; HRSA's Independent Investigation Revealed Clear Negligence After Previous OPTN Board Claimed To Find No Major Concerns In Internal Review'
https://www.hhs.gov/press-room/hrsa-to-reform-organ-transplant-system.html#:~:text=It%20found%3A,serious%20ethical%20and%20legal%20questions.
07-22 01:17
Optinose Acquired by Paratek Pharmaceuticals for $330 Million
Optinose ( ($OPTN) ) has provided an update. Optinose, a company involved in th...
05-21 20:57
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
HC Wainwright & Co. Reiterates Neutral on OptiNose, Maintains $9 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates OptiNose (NASDAQ:OPTN) with a Neutral and maintains $9 price target.
05-19 18:39
Optinose Stockholders Approve Merger with Paratek
Optinose ( ($OPTN) ) just unveiled an update. On May 16, 2025, OptiNose, Inc. h...
05-17 00:57
OptiNose GAAP EPS of -$0.03 beats by $0.76, revenue of $22.42M beats by $1.6M
OptiNose press release (NASDAQ:OPTN): Q4 GAAP EPS of -$0.03 beats by $0.76. Revenue of $22.42M (+12.8% Y/Y) beats by $1.6M. The company had cash and cash equivalents of $84.5 million as of December 31...
03-26 19:26
美股大行评级 | 高盛：上调Adaptive Biotechnologies评级至"买入"，目标价从8美元升至9美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1110125309827231744.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Amprius Technologies(AMPX)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 韦德布什：维持Monte Rosa Therapeutics(GLUE)"跑
03-24 07:31
美股大行评级 | Piper Sandler：上调ACV Auctions, Inc. Class A评级至"超配"，目标价从18美元升至20美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1109762517053050881.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Femasys Inc Ordinary Shares(FEMY)"买入"评级，目标价从12美元升至15美元</p> <p>• Chardan Capital：维持Pri
03-21 09:11
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders
NEW YORK, March 20, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
03-21 00:31
OptiNose Stock Is Soaring Today: What's Going On?
OptiNose Inc (NASDAQ:OPTN) shares are trading higher Thursday after Paratek Pharmaceuticals announced a deal to acquire the company.
03-20 21:22
